Table 1.
Measurements of hepatic hemodynamic parameters
| Time |
Flow portal vein (L/min) |
Flow umbi-lical vein (L/min) | HVPG (mmHg) | Blood pressure (mmHg) | Heart rate (beats/min) | ||
| Duplex | MRI | MRI | |||||
| Start | 02/2009 | 0.97 | 0.85 | 0.53 | 10.5 | 130/87 | 69 |
| 1 h post Vardenafil 10 mg | 02/2009 | 1.24 | 0.99 | 0.56 | 9.0 (-14%) | 121/75 | 61 |
| 4 mo Tadalafil 5 mg/d | 06/2009 | 1.21 | 0.56 | 10.5 | 127/77 | 64 | |
| Without PDE-5-I | 10/2009 | 12 | |||||
| 1h post Tadalafil 5 mg | 10/2009 | 1.28 | 0.99 | 0.53 | 10.0 (-15%) | 110/70 | 84 |
| 11 mo Tadalafil 5 mg/d | 03/2010 | 1.32 | 1.33 | 10.5 | 120/80 | 70 | |
| 20 mo Tadalafil 5 mg/d | 10/2010 | 1.34 | 115/75 | 77 | |||
| 26 mo Tadalafil 5 mg/d | 04/2011 | 1.26 | 1,34 | 125/80 | 72 | ||
| 32 mo Tadalafil 5 mg/d | 10/2011 | 1.25 | 117/70 | 66 | |||
| 46 mo Tadalafil 5 mg/d | 12/2012 | 1.20 | 131/85 | 70 | |||
| 53 mo Tadalafil 5 mg/d | 07/2013 | 1.20 | 110/70 | 68 | |||
| 60 mo Tadalafil 5 mg/d | 02/2014 | 1.20 | 115/75 | 78 | |||
| 70 mo Tadalafil 5 mg/d | 12/2014 | 1.20 | 110/70 | 70 | |||
| 81 mo Tadalafil 5 mg/d | 11/2015 | 1.40 | 135/85 | 65 | |||
| 84 mo Tadalafil 5 mg/d | 12/2016 | 1.061 | 135/75 | 85 | |||
| 93 mo Tadalafil 5 mg/d | 09/2017 | 1.29 | 110/70 | 80 | |||
1
The duplexsonography at month 84 was done with a different device.